Literature DB >> 9120182

Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity.

P J Chowienczyk1, G F Watts, A S Wierzbicki, J R Cockcroft, S E Brett, J M Ritter.   

Abstract

OBJECTIVES: We sought to determine whether hypertriglyceridemia in patients with lipoprotein lipase (LPL) dysfunction is associated with endothelial dysfunction in resistance vessels of the forearm vasculature.
BACKGROUND: Vasodilator responses to acetylcholine, acting through stimulation of nitric oxide (NO) release from the endothelium, are impaired in hypercholesterolemia and normalized by L-arginine, suggesting dysfunction of the L-arginine/NO pathway. Similar abnormalities have been reported in conditions associated with hypertriglyceridemia, such as non-insulin-dependent diabetes. The relation between endothelial function and plasma triglyceride concentrations has, however, not previously been studied in vivo.
METHODS: We examined forearm blood flow responses to brachial artery infusions of acetylcholine (alone and with L-arginine) and nitroprusside (an NO donor) in 17 patients with severe hypertriglyceridemia (mean [+/- SD] plasma triglyceride concentration 1,914 +/- 1,288 mg/dl) but normal low density lipoprotein cholesterol (89 +/- 31 mg/dl) and in 34 normolipidemic control subjects. Severe LPL dysfunction was demonstrated in 10 of 17 patients.
RESULTS: Acetylcholine (7.5 and 15 microg/min) produced similar forearm blood flow responses in hypertriglyceridemic patients (mean [+/- SEM] 7.7 +/- 0.9 and 10.5 +/- 1.2 ml/min per 100 ml) and in control subjects (7.5 +/- 0.6 and 11.0 +/- 0.8 ml/min per 100 ml, p = 0.78 by analysis of variance). Responses to acetylcholine co-infused with L-arginine (10 mg/min) and nitroprusside (3 and 10 microg/min) were also similar in hypertriglyceridemic patients and control subjects (p = 0.93 and p = 0.27 for acetylcholine with L-arginine and nitroprusside, respectively). The ratio response to acetylcholine/response to nitroprusside differed between hypertriglyceridemic patients and control subjects by only 1%. The study had >90% power (alpha = 0.05) to detect a difference >30% in this ratio.
CONCLUSIONS: Severe hypertriglyceridemia associated with LPL dysfunction is not associated with the degree of endothelial dysfunction seen in moderate hypercholesterolemia when responses to acetylcholine are impaired by >40%.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120182     DOI: 10.1016/s0735-1097(97)00033-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

Review 2.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

3.  Vascular dysfunction in Type 2 diabetes: emerging targets for therapy.

Authors:  Yoonjung Park; Junxi Wu; Hanrui Zhang; Yong Wang; Cuihua Zhang
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-03

4.  Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease).

Authors:  A S Wierzbicki; G F Watt; J Lynas; A F Winder; R Wray
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

Review 5.  Metabolic syndrome and endothelial dysfunction.

Authors:  Alessia Fornoni; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

6.  Empagliflozin's Ameliorating Effect on Plasma Triglycerides: Association with Endothelial Function Recovery in Diabetic Patients with Coronary Artery Disease.

Authors:  Takahiro Sawada; Kenzo Uzu; Naoko Hashimoto; Tetsuari Onishi; Tomofumi Takaya; Akira Shimane; Yasuyo Taniguchi; Yoshinori Yasaka; Takeshi Ohara; Hiroya Kawai
Journal:  J Atheroscler Thromb       Date:  2019-10-18       Impact factor: 4.928

7.  Triglycerides are a predictive factor for arterial stiffness: a community-based 4.8-year prospective study.

Authors:  Xiaona Wang; Ping Ye; Ruihua Cao; Xu Yang; Wenkai Xiao; Yun Zhang; Yongyi Bai; Hongmei Wu
Journal:  Lipids Health Dis       Date:  2016-05-18       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.